Alethea Capital Management, LLC Portfolio Holdings

Alethea Capital Management, LLC

  • $116 Million
  • Q4 2024

Alethea Capital Management, LLC has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $116 Million distributed in 30 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Axsome Therapeutics, Inc. with a value of $62.1M, Spdr Bloomberg 1 3 Month T Bil with a value of $27.3M, Avidity Biosciences, Inc. with a value of $12.2M, Kura Oncology, Inc. with a value of $4.86M, and Ishares Barclays 20+ Year Trea with a value of $2.02M.

Examining the 13F form we can see an decrease of $21.2M in the current position value, from $138M to 116M.

Alethea Capital Management, LLC is based out at San Diego, CA

Below you can find more details about Alethea Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $116 Million
Healthcare: $80.3 Million
ETFs: $29.7 Million
Real Estate: $1.6 Million
Energy: $1.36 Million
Consumer Defensive: $1.19 Million
Technology: $795,000
Utilities: $793,000
Financial Services: $629,000
Other: $19,000

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$5.38B
$62.1 Million 53.37% of portfolio
734,317
Q4 2024 Reduced 0.57%
$0
$27.3 Million 23.47% of portfolio
298,752
Q4 2024 Reduced 7.82%
$1.49B
$12.2 Million 10.51% of portfolio
420,871
Q4 2024 Reduced 1.54%
$490M
$4.86 Million 4.18% of portfolio
558,442
Q4 2024 Added 0.89%
$0
$2.02 Million 1.73% of portfolio
23,123
Q1 2024 Reduced 0.67%
$21.6B
$461,000 0.4% of portfolio
10,536
Q4 2024 New
$101B
$437,000 0.38% of portfolio
8,366
Q4 2024 New
$96.4B
$428,000 0.37% of portfolio
2,337
Q4 2024 New
$20.7B
$391,000 0.34% of portfolio
12,246
Q4 2024 New
$145B
$393,000 0.34% of portfolio
14,830
Q4 2024 New
$10.4B
$399,000 0.34% of portfolio
4,716
Q4 2024 New
$10.6B
$394,000 0.34% of portfolio
4,446
Q4 2024 New
$30.3B
$401,000 0.34% of portfolio
12,303
Q4 2024 New
$25.8B
$392,000 0.34% of portfolio
2,395
Q4 2024 New
$89.6B
$394,000 0.34% of portfolio
3,662
Q4 2024 New
$6.06B
$385,000 0.33% of portfolio
16,672
Q4 2024 New
$234B
$369,000 0.32% of portfolio
3,718
Q4 2024 New
$12.1B
$369,000 0.32% of portfolio
8,813
Q4 2024 New
$167B
$346,000 0.3% of portfolio
1,330
Q4 2024 New
$0
$346,000 0.3% of portfolio
7,925
Q4 2024 Reduced 1.18%
$49.2B
$314,000 0.27% of portfolio
2,566
Q4 2024 New
$25.7B
$303,000 0.26% of portfolio
2,884
Q4 2024 New
$27.9B
$265,000 0.23% of portfolio
4,515
Q4 2024 New
$22.4B
$273,000 0.23% of portfolio
8,367
Q4 2024 New
$17.7B
$208,000 0.18% of portfolio
763
Q4 2024 New
$0
$97,000 0.08% of portfolio
10,658
Q3 2023 Reduced 18.82%
$557M
$71,000 0.06% of portfolio
12,000
Q3 2021 Reduced 14.29%
$581M
$19,000 0.02% of portfolio
10,000
Q4 2024 New
Cidara Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 82.09%

Summary

  • Portfolio
  • No. of Stocks 30
  • Current Value $116 Million
  • Prior Value $138 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 21 stocks
  • Additional Purchases 1 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 5 stocks
Track This Portfolio

Track Alethea Capital Management, LLC Portfolio

Follow Alethea Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alethea Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alethea Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email